, related to (Alexa Fluor 546, red) and with rabbit anti-Arl8 antisera followed by Alexa Fluor-488 (green) conjugated donkey anti-rabbit. The antiserum dominantly recognized LAMP1 + lysosomes, confirming this as the location of endogenous Arl8b. (second row) In contrast, the early endosome marker EEA1 showed no colocalization with Arl8b, indicating Arl8b did not localize to early endosomes. (third row) As in A,B, & C. M-6-PR has a complex intracellular distribution (Golgi, transGolgi, late endosomes, and partially to lysosomes). Arl8b did not show a significant distribution to M-6-PR + compartments. (fourth row) The ER marker Calnexin showed no colocalization with Arl8b, indicating the molecule did not localize to this compartment. (fifth row) The Golgi marker GM130 showed no colocalization with Arl8b, indicating Arl8b did not localize to this compartment. Shown are representative sample images. Similar results were obtained in RAW macrophage cells. All scale bars=10m. B. Quantification of Arl8b localization to intracellular compartments: Quantification of colocalization (Metamorph) between Arl8b antisera staining and the indicated markers for >30 cells for each staining in HeLa cells is shown. The pool of molecules recognized by Arl8b antisera dominantly colocalized with lysosomal marker LAMP1 and failed to colocalize significantly with markers of other compartments. C. mCD1d was delayed entering lysosomes in Arl8b silenced cells: mAb 19G11 was bound to CD1d in Arl8b silenced or control RAW cells at 4°C for 30 min. Cells were then warmed to 37°C for indicated times (0 minutes, 20 minutes, 60 minutes), fixed, and stained with anti-19G11 secondary (red) and anti-LAMP1 (green). (left panels) Representative images from 60 minute timepoint for Arl8b silenced (bottom row) and control cells (top row). The inset shows strong accumulation of CD1d in LAMP1 + lysosomes in control cells, and little or no CD1d in Lamp1 + compartments in Arl8b silenced cells. (right panel) Colocalization for >20 cells for each sample at each timepoint was quantified as described (methods). D. Steady state localization of markers to lysosomes was not impacted by Arl8b silencing: (first and second row) HeLa cells were fixed, permeabilized, and stained for saposin C (SAPC, middle panels) and LAMP1 in control (first row) and Arl8b silenced (second row) cells. Similar to control cells, Arl8b silenced cells show strong colocalization between SAPC and LAMP1. This suggests that Arl8b silencing did not result in loss of Saposin molecules from lysosomes. (third and fourth rows) RAW cells were stained for cathepsin D (middle panels) and LAMP1 in control (third row) and Arl8b silenced (fourth row) RAW cells. In both Arl8b silenced and control cells, a dominant portion of cathepsin D staining colocalizes with LAMP1. (fifth and sixth rows) Arl8b silenced (sixth row) and control (fifth row) HeLa cells were transfected with a Rab9-GFP construct, fixed, and stained for LAMP1 (red, left panels). Rab9 displays a complex distribution, labeling late endosomes, lysosomes, and trans-Golgi. Note that a portion of Rab9 + vesicles colocalized with LAMP1 + vesicles in control cells (fifth row). In Arl8b silenced cells (sixth row), a similar portion of Rab9 continued to colocalize with Arl8b. These results suggest localization of a variety of markers to lysosomes (SAP C, cathepsin D, Rab9) at steady state was unaltered in Arl8b silenced cells. Figure S4: Pulldown with GST-Arl8b identified members of the HOPS complex: Lysates from RAW macrophages were probed with GST-Arl8b or GST. Eluates were run on SDS-PAGE. Bands which appeared specifically in the GST-Arl8b lane were cut, partially digested, and analyzed by mass spectrometry. The number of unique peptides identified corresponding to each interaction partner is listed at right. We restricted our initial analysis to those genes where at least two unique peptides were identified in this manner. Previously, Arl8b has been shown to bind -tubulin. Encouragingly, we identified a number of tubulin subunits as potential binding partners of Arl8b. We also identified two members of the VPS-C core of the HOPS complex (see The geometric MFI for LAMP1 on latex beads repurified 60 minutes after addition for both control and Arl8b silenced RAW cells is plotted with or without cytochalasin D pretreatment. Note that in both Arl8b silenced and control cells drug treatment drastically reduced the acquisition of LAMP1 on latex beads, indicating LAMP1 acquisition depended on actin polymerization. This strongly suggests LAMP1 acquisition on beads was due to phagocytosis followed by fusion with lysosomes. B. Phagocytosed beads isolated from Arl8b silenced cells did not show a delay in transferrin receptor acquisition. In contrast to LAMP1, acquisition of transferrin receptor on bead phagosomes isolated from Arl8b silenced cells was not delayed compared to control cells (compare B to Figure 7B ). There was a slight increase in transferrin receptor levels detected on bead phagosomes isolated 30 minutes after infection in Arl8b silenced cells, suggesting a connection between phagosomal maturation and acquisition of lysosomal markers (LAMP1) and loss of early endocytic markers (transferrin receptor). All vectors listed as TRC are commercially available through Open Biosystems and Sigma. We are happy to distribute vectors cloned in the lab. *=Each of these "control" shRNA hairpins was used in almost every experiment and found to give similar results. Additionally, results with transduction by these control shRNA were identical to nontransduced (uninfected) cells in all experiments except where both controls are shown (Figure 1b/1c) . For clarity, all experiments in the manuscript utilize shMISSION transduced cells as the control unless otherwise noted. **=Figures targeting murine Arl8b utilize this hairpin unless otherwise noted ***=Figures targeting human Arl8b utilize this hairpin unless otherwise noted 
Supplemental Experimental Procedures

Expression constructs:
Arl8b expression constructs were obtained from Origene and cloned into pcDNA3.1 using the BamH1 and EcoR1 restriction sites. Point mutants were designed and obtained using Stratagene site directed mutagenesis kits (Agilent). GFP-Rab7 and GFP-Rab9 expression constructs were obtained from Dr. Steve Caplan. GFP-RILP and GFP-ORLP1 were obtained from Dr. Jacques Neefjes. VPS expression constructs were obtained from Drs. J Wade Harper, Victor Faundez, and Robert Piper. All expression constructs were sequence verified using standard vector primers. GST-Arl8b, GST-Arl8b mutants, and GST-RILP were expressed from pGEX 4T-3 in BL-21 cells, purified using standard methods. HisArl8b was cloned in pet15b vector using NdeI and BamH1 restriction enzymes and retransformed in BL-21 strain for protein production. Bacteria were induced with 0.5mM IPTG for 5 hours at 30 degrees C. After sonication, His-Arl8b was purified from the bacterial lysates using TALON cobalt resin (Clontech). Purified protein was eluted from the beads by using elution buffer (Clontech, HisTALON buffer set) Lentiviral transduction: For lentiviral transduction, U937 cells were plated in 96-well round bottom plates (10,000/well, Corning) in polybrene (8 g/mL, SIGMA), and mixed with 10 L of viral supernatant (Day 0). Puromycin was added after 24-48 hours at 2.5 g/mL for a minimum of three days to select transductants. Monocyte-derived DC were transduced with lentivirus by spinoculation at 2000 rpm, 30 minutes at 25 degrees C (Day 2), puromycin added (2.0 g/mL, Day 3) and analyzed for CD1 presentation (Day 6-7). HeLa and RAW cells were plated at 100,000/well in 6-well plates (Corning) in 5 g/mL Polybrene and transduced by addition of 100 uL viral supernatant. 24-48 hours later, puromycin was added at 2.5 g/mL (HeLa) and 5 g/mL (RAW) to select transductants and experiments performed on Days 5-21 following transduction.
GST pulldowns: GST, GST-Arl8b, and GST-Arl8b mutants were bound to GST beads. Lysates were prepared in 0.5% CHAPS buffer containing GTPγS and were incubated with purified bound GST protein overnight followed by washes with PBS or PBS containing GTPγS. Eluates were run on SDS-PAGE and subjected to electrospray ionization tandem mass spectrometry (LC-MS/MS) to discover Arl8b interacting proteins (Supplementary Figure 4) or were western blotted with anti-HA antibody (Figure 4) . His-Arl8b was first incubated with 0.5mM GTPS in a nucleotide loading reaction. The GTP-loaded Arl8b was then incubated with Talon resin for 30 mins at 4 degrees followed by blocking of beads with 5% BSA for 1 hour. Incubation of GST proteins : GST, GST-Vps41 (Novus biologicals) or GST-RILP-Rab7 Binding domain was performed at 4 degrees C for 3 hours in 20mM Tris-HCl Ph 7.4 , 150Mm NaCl, 1mM MgCl2, 5% Glycerol , 0.5% NP-40. After the incubations, beads were pelleted by centrifugation (500g for 4 minutes at 4 degrees) followed by three washes in 25mM HEPES, 300mM NaCl, 90mM KCl, 1mM MgCl2, 0.2%Triton X-100 + 0.5mM GTPS and then analyzed by SDS-PAGE. Western blotting was performed using anti-GST-HRP antibody (Millipore) to detect the bound proteins. Coomassie brilliant blue and Silver stain were performed to detect His-Arl8b and GST-tagged proteins respectively.
Yeast two hybrid analysis:
The Saccharomyces cerevisiae strain AH109 (Clontech) was maintained on Yeast extract, Peptone, Dextrose (YPD) agar plates. Transformation was carried out by the lithium acetate procedure as described in the instructions for the MATCHMAKER two-hybrid kit (Clontech). For colony growth assays, AH109 cotransformants were streaked on plates lacking leucine and tryptophan and allowed to grow at 30 degrees C for 5 days until colonies were large enough for further assays. An average of three to four colonies was then chosen and suspended in water, equilibrated to the same optical density of 600 nm and replated on plates lacking leucine and tryptophan (+HIS) as well as plates also lacking histidine (−HIS).
Arl8b antisera and western blotting
To generate Arl8b antisera, peptide was conjugated to KLH as a protein carrier, injected into rabbit, and boosted bi-weekly for 6 weeks. Rabbit IgG was then affinity purified against peptide. Lysates from 10 7 U937 or 10 7 RAW cell equivalents/lane were made in 0.5% Triton X-100 and analyzed on 15% SDS-PAGE, transferred to PVDF membranes (Bio-Rad) and blotted with Rabbit anti-Arl8b IgG (1 ug/mL) followed by donkey-anti rabbit HRP (Jackson Labs) at 1:30,000 dilution. Membranes were stripped and reprobed with anti-human -actin (Abcam) for human cell lysates or anti-murine GAPDH (Abcam) followed by appropriate secondary HRP conjugates (Jackson Labs). All blots were developed with ECL reagents and exposed to film Colocalization analysis using MetaMorph Imaging software: Images from control or Arl8b silenced cells were acquired using identical laser power and gain settings on a single day within an experiment. Each channel (R,G, B) was considered separately with each pixel assigned an intensity value 0-255 with great care taken to assure that no pixel was saturated in any image used for quantification (no values = 255) . A lower threshold is set whereby areas of the image not containing cells or staining are excluded, and the same threshold was always applied to control and Arl8b silenced cells. This value was 10-30 depending on the stain and never excluded visibly positive regions. The software then calculates the area overlapping between two channels where both stains are positive over the lower threshold and reports it in percentage terms. This analysis was utilized to give the reported co-localization values in Phagosomal Assays 3 m latex beads were purchased (Polysciences Inc) and coated by rotation with .4 mg/mL murine IgG (Sigma) for 1 hour at 37°C and added to RAW cells at a ratio of 10 beads/cell. Bead/cell mixtures were centrifuged at 300g to synchronize uptake. Following incubation for indicated times at 37°C, coverslips were washed 3x in complete DMEM to remove unbound beads, and fixed and stained as described. E. coli (EPEC E1348/69, gift from Lynn Bry, Harvard University) were added to RAW cells at multiplicity of infection (MOI) of 20 and centrifuged at 300g for 5 mins. The mix was then incubated for 60 mins at 37°C, 5% CO2 followed by treatment with 100 g/mL gentamycin and chase
